Re: Adjuvant treatment of high-risk, radically resected gastric cancer patients with 5-fluorouracil, leucovorin, cisplatin, and epidoxorubicin in a randomized controlled trial.
Nicola Fazio, Roberto Biffi, Giuseppe Curigliano, Katia Lorizzo, Maria Giulia Zampino, Filippo de Braud, Antonio Chiappa, Arnaud Roth, Aron Goldhirsch
Journal: Journal of the National Cancer Institute
2007;99(17):1345-6; author reply 1346-7
NED wishes to thank the following organisations for their support:
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.